Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD2 | O60906 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | F2 | P00734 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | HTR1B | P28222 | 3/20 | 0.38 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.38 |
| ▸ | CHAT | P28329 | 2/20 | 0.37 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.36 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4819774 | 0.81 | SMPD2 (0.42) | SMPD2ALDH1A1F2LMNACHAT | |
| SCHEMBL6027641 | 0.79 | SMPD2 (0.41) | SMPD2ALDH1A1F2LMNACHAT | |
| SCHEMBL27813589 | 0.79 | SMPD2 (0.44) | SMPD2CYP1A2CYP2C19ALDH1A1F2 | |
| SCHEMBL28299894 | 0.77 | CHAT (0.41) | SMPD2ALDH1A1F2LMNACHAT | |
| SCHEMBL8325158 | 0.77 | TAAR1 (0.44) | SMPD2CYP2D6ALDH1A1F2LMNA | |
| SCHEMBL3243723 | 0.76 | ALDH1A1 (0.45) | SMPD2ALDH1A1F2LMNACHAT | |
| SCHEMBL6709477 | 0.75 | SMPD2 (0.39) | SMPD2ALDH1A1F2LMNACHAT | |
| SCHEMBL28231663 | 0.74 | CNR1 (0.46) | SMPD2ALDH1A1F2LMNACHAT | |
| SCHEMBL10675341 | 0.73 | CYP1A2 (0.46) | SMPD2CYP1A2CYP2D6CYP2C19HTR1B | |
| SCHEMBL6709427 | 0.73 | ALDH1A1 (0.50) | SMPD2CYP1A2ALDH1A1F2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1392315-A1 | METHODS OF TREATING ALZHEIMER'S DISEASE | Elan Pharmaceuticals, Inc. (US) | 2004-03-03 | — | — | EP | disclosed |
| WO-2002100410-A1 | METHODS OF TREATING ALZHEIMER'S DISEASE | ELAN PHARMACEUTICALS, INC. (US) | 2002-12-19 | — | — | WO | disclosed |